Clinical Trials Sponsored by Minerva Neurosciences

Total 364 results

Minerva Neurosciences

Completed

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Healthy Subjects

Ireland
Minerva Neurosciences

Completed

Pharmacokinetic Study of MIN-101 in Healthy Subjects

Schizophrenia

United Kingdom
Minerva Neurosciences

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Negative Symptoms in Schizophrenia

United States
Minerva Neurosciences

Completed

Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia

Negative Symptoms of Schizophrenia

United States, Bulgaria, Poland, Ukraine
Minerva Neurosciences

Completed

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Georgia, Moldova, Republic of, Poland, Ukraine
Minerva Neurosciences

Completed

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

Healthy Subjects

Ireland
Minerva Surgical, Inc.

Completed

Registry Study of Genesys HTA for Treatment of Menorrhagia (Genesys HTA)

Menorrhagia

United States
Minerva Surgical, Inc.

Completed

A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System

Menorrhagia Due to Benign Causes

Mexico
Minerva Surgical, Inc.

Completed

A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System

Menorrhagia Due to Benign Causes

Canada
Minerva Surgical, Inc.

Completed

Symphion® System In-Office Study

Uterine Leiomyomas | Endometrial Polyps

United States
Minerva Surgical, Inc.

Completed

Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation

Menorrhagia

United States, Canada, Mexico
Minerva Surgical, Inc.

Completed

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

Menorrhagia Due to Benign Causes

Hungary
Minervax ApS

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. (MVX13211)

Infection by Streptococcus Group B

United Kingdom
Minervax ApS

Completed

Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine

Group B Streptococcus Infection

United Kingdom
Hellenic Atherosclerosis Society
Minerva SA

Completed

Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet

Hypercholesterolemia

Greece
Boston Neurosciences

Unknown

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Intracranial Hypertension | Abnormality of Intracranial Pressure

United States
Samson NeuroSciences

Unknown

Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm

Aneurysmal Subarachnoid Hemorrhage | Cerebral Vasospasm

Germany, Czech Republic, Israel
Innodem Neurosciences

Not yet recruiting

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

Multiple Sclerosis

Canada
Innodem Neurosciences

Recruiting

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Multiple Sclerosis

Canada
Innodem Neurosciences

Recruiting

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

Cancer-related Cognitive Impairment

Canada
Innodem Neurosciences

Recruiting

Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease

Alzheimer's Disease

Canada
Minervax ApS
Simbec Research

Completed

Group B Streptococcus Vaccine in Healthy Females (MVX0002)

Group B Strep Infection

United Kingdom
Innodem Neurosciences

Suspended

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Neurological Disorders

Canada
Minervax ApS
Iqvia Pty Ltd

Active, not recruiting

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
Mindera Health

Not yet recruiting

Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2)

Psoriasis
Mindera Health

Not yet recruiting

A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH)

Plaque Psoriasis
Global Neurosciences Institute

Recruiting

Verapamil for Neuroprotection in Stroke

Ischemic Stroke

United States
Gate Neurosciences, Inc

Completed

Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

Major Depressive Disorder

United States
Amygdala Neurosciences, Inc.

Completed

A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

Healthy Volunteers

United States
Alto Neuroscience

Recruiting

PD, PK, and Safety of ALTO-203 in Patients With MDD

Anhedonia | Major Depressive Disorder

United States
Wave Neuroscience

Recruiting

EEG Personalized Transcranial Magnetic Stimulation (eTMS) for Post-Traumatic Stress Disorder

Stress Disorders, Post-Traumatic

United States
Alto Neuroscience

Recruiting

Study of ALTO-300 in MDD

Major Depressive Disorder

United States
QuantalX Neuroscience

Completed

DELPHI in Subjects at Risk for Stroke and Dementia

Smoking | Stroke | Hypertension | Sleep Disorder | Cognitive Impairment | Atrial Fibrillation | Transient Ischemic Attack | Dyslipidemias | Familial Alzheimer Disease | Diabete Mellitus | Overweight and Obesity | Cardiac Disease

United States, Israel
Wave Neuroscience

Completed

Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression

Major Depressive Disorder (MDD)

United States, China
Wave Neuroscience

Completed

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Autism Spectrum Disorder

United States
Northstar Neuroscience

Terminated

Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder (PROSPECT)

Depressive Disorder | Depression

United States
ProMis Neurosciences, Inc

Recruiting

A Phase 1a Study of PMN310 In Healthy Volunteers

Healthy Participants

United States
Gate Neurosciences, Inc

Completed

AGN-241751 in the Treatment of Major Depressive Disorder

Depressive Disorder, Major

United States
Alto Neuroscience

Recruiting

Phase 2b Study of ALTO-100 in MDD

Major Depressive Disorder

United States
Alto Neuroscience

Completed

ALTO-100 in MDD and/or PTSD

Post Traumatic Stress Disorder | Major Depressive Disorder

United States
Wave Neuroscience

Completed

Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD

Stress Disorders, Post-Traumatic

United States
Wave Neuroscience

Completed

A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD (MeRT-USC-009)

ADHD

United States
Wave Neuroscience

Completed

A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

Autistic Disorder

United States
Minervax ApS
Larix A/S

Completed

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Group B Streptococcal Infection

Denmark, United Kingdom, South Africa
Minervax ApS
Simbec-Orion Group

Enrolling by invitation

A Follow up Study of Group B Streptococcus Vaccine (GBS-NN/NN2 Vaccine) in Healthy Volunteers

Group B Streptococcus Infection

United Kingdom
Global Neurosciences Institute

Recruiting

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
Gate Neurosciences, Inc

Completed

AGN-241751 in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States
Gate Neurosciences, Inc

Terminated

Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

Major Depressive Disorder | Excessive Sleepiness

United States
Innodem Neurosciences
Syneos Health

Recruiting

ETNA-MS Device Validation Study (ETNA-MS)

Multiple Sclerosis

United States
Innodem Neurosciences
Novartis Pharmaceuticals

Recruiting

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

Multiple Sclerosis

Canada

3

Subscribe